Aptevo Therapeutics Inc (APVO):企業の財務・戦略的SWOT分析

◆英語タイトル:Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH2536587FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Aptevo Therapeutics Inc (APVO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aptevo Therapeutics Inc (Aptevo) is a biotechnology company that develops and commercializes oncology and hematology therapeutics. Its pipeline products include APVO436 for the treatment of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML); ALG.APV-527 for potential treatment of a broad spectrum of cancers including mesothelioma, cervical, prostate, renal, breast, non-small-cell-lung, gastric, colorectal and bladder cancers; APVO603 for solid tumors. The company has received Orphan Drug Designation (ODD) for its pipeline product APVO436 from the US FDA for the treatment of acute myelogenous leukemia (AML). The pipeline immuno-oncology candidates are built on its proprietary Adaptir platform technology. Aptevo is headquartered in Seattle, Washington, the US.

Aptevo Therapeutics Inc Key Recent Developments

Mar 31,2021: Aptevo Therapeutics reports 2020 financial results and provides business update
Nov 10,2020: Aptevo Therapeutics reports third quarter financial results and provides business update
Aug 14,2020: Aptevo Therapeutics reports second quarter 2020 financial results
May 13,2020: Aptevo Therapeutics reports first quarter 2020 financial results
Mar 25,2020: Aptevo Therapeutics reports 2019 financial results and provides business update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Aptevo Therapeutics Inc – Key Facts
Aptevo Therapeutics Inc – Key Employees
Aptevo Therapeutics Inc – Key Employee Biographies
Aptevo Therapeutics Inc – Major Products and Services
Aptevo Therapeutics Inc – History
Aptevo Therapeutics Inc – Company Statement
Aptevo Therapeutics Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Aptevo Therapeutics Inc – Business Description
R&D Overview
Aptevo Therapeutics Inc – Corporate Strategy
Aptevo Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Aptevo Therapeutics Inc – Strengths
Aptevo Therapeutics Inc – Weaknesses
Aptevo Therapeutics Inc – Opportunities
Aptevo Therapeutics Inc – Threats
Aptevo Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Aptevo Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 31, 2021: Aptevo Therapeutics reports 2020 financial results and provides business update
Nov 10, 2020: Aptevo Therapeutics reports third quarter financial results and provides business update
Aug 14, 2020: Aptevo Therapeutics reports second quarter 2020 financial results
May 13, 2020: Aptevo Therapeutics reports first quarter 2020 financial results
Mar 25, 2020: Aptevo Therapeutics reports 2019 financial results and provides business update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Aptevo Therapeutics Inc, Key Facts
Aptevo Therapeutics Inc, Key Employees
Aptevo Therapeutics Inc, Key Employee Biographies
Aptevo Therapeutics Inc, Major Products and Services
Aptevo Therapeutics Inc, History
Aptevo Therapeutics Inc, Key Competitors
Aptevo Therapeutics Inc, Ratios based on current share price
Aptevo Therapeutics Inc, Annual Ratios
Aptevo Therapeutics Inc, Annual Ratios (Cont...1)
Aptevo Therapeutics Inc, Interim Ratios
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Aptevo Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Aptevo Therapeutics Inc (APVO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • aap Implantate AG (AAQ):企業の製品パイプライン分析2018
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • Orlando Utilities Commission:企業の発電所・SWOT分析2018
    Orlando Utilities Commission - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Nestle (Malaysia) Bhd:企業の戦略・SWOT・財務情報
    Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report Summary Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AVI Limited:企業の戦略・SWOT・財務情報
    AVI Limited - Strategy, SWOT and Corporate Finance Report Summary AVI Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • mBio Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary MBio Diagnostics Inc (MBio) is a medical device company that provides clinical diagnostics and sample testing solutions. The company offers MBio multiplex analyzer and disposable cartridges. Its MBio Array System is a fluorescence immunoassay system that provides measurement of analytes from …
  • NIBE Industrier AB:企業のM&A・事業提携・投資動向
    NIBE Industrier AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NIBE Industrier AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Takenaka Corporation:企業の戦略・SWOT・財務情報
    Takenaka Corporation - Strategy, SWOT and Corporate Finance Report Summary Takenaka Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mahindra & Mahindra Ltd (M&M):企業の財務・戦略的SWOT分析
    Mahindra & Mahindra Ltd (M&M) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Granite REIT (GRT.UN):企業の財務・戦略的SWOT分析
    Summary Granite REIT (Granite), formerly Granite Real Estate Inc is a construction company that offers real estate investment services. The company acquires, develops, constructs and manages industrial properties. It offers services such as site development, re-zoning to specific uses, assisting wit …
  • University of Tennessee Research Foundation-製薬・医療分野:企業M&A・提携分析
    Summary University of Tennessee Research Foundation (UTRF), a subsidiary of University of Tennessee is a non profit organization that promotes research and education. The organization offers agriculture, chemistry and materials; energy, animal health, engineering, human health, research tools and so …
  • QBE Insurance (Vietnam) Company Ltd:企業の戦略的SWOT分析
    QBE Insurance (Vietnam) Company Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Genesee & Wyoming Inc.:企業のM&A・事業提携・投資動向
    Genesee & Wyoming Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genesee & Wyoming Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Zeria Pharmaceutical Co Ltd (4559):企業の財務・戦略的SWOT分析
    Summary Zeria Pharmaceutical Co Ltd (Zeria), formerly Zeria Yakusho Kenkyusho Co Ltd is a pharmaceutical company that manufactures pharmaceutical and non-pharmaceuticals, veterinary pharmaceuticals, industrial chemicals and reagents. The company imports and exports healthcare products such as cosmet …
  • CEZ, a. s.:企業の戦略・SWOT・財務分析
    CEZ, a. s. - Strategy, SWOT and Corporate Finance Report Summary CEZ, a. s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Big Rivers Electric Corporation:発電所・企業SWOT分析
    Big Rivers Electric Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Fibra Uno Administracion SA de CV:企業の戦略・SWOT・財務情報
    Fibra Uno Administracion SA de CV - Strategy, SWOT and Corporate Finance Report Summary Fibra Uno Administracion SA de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • China Petroleum & Chemical Corporation (600028)-石油・ガス分野:企業M&A・提携分析
    Summary China Petroleum & Chemical Corporation (Sinopec), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and producti …
  • BP Australia Group Pty Ltd:企業の戦略的SWOT分析
    BP Australia Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Sinotrans Ltd:企業の戦略・SWOT・財務情報
    Sinotrans Ltd - Strategy, SWOT and Corporate Finance Report Summary Sinotrans Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Calithera Biosciences Inc (CALA):企業の財務・戦略的SWOT分析
    Summary Calithera Biosciences Inc (Calithera) is a clinical-stage bio-pharmaceutical company that discovers and develops novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. The company’s product pipeline includes CB-839, a glutaminas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆